Can a simple blood test after pancreatic surgery save lives?
NCT ID NCT06126601
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 150 patients who have had part of their pancreas removed. Researchers will measure blood levels of amylase and lipase before, during, and after surgery to see if high levels can predict serious complications like pancreatitis. The goal is to improve how doctors identify and treat these problems early.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better early detection and management of pancreatitis after pancreatic surgery, improving patient safety.
- What could go wrong
- This is an observational study, not testing a new treatment. It may not lead to immediate changes in care, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERAMYLASEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital Dresden, Dept. Visceral, Thoracic and Vascular Surgery
RECRUITINGDresden, 01307, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Chilled water may curb pancreatitis risk after Bile-Duct procedure
- New device aims to seal pancreas during robotic surgery, cutting leak risk
- Pancreas removal study tracks diabetes worsening after surgery
- Pancreas removal study to uncover diabetes danger
- New app aims to ease pancreatic cancer care at home
- Routine insulin after pancreas surgery may be unnecessary for some patients